Achillion Pharmaceuticals, Inc. v. Comm’r Rev. Srvcs., SC 18175 (Conn. Sup. Ct. 2009)

In this tax appeal, we consider whether the trial court properly interpreted and applied the terms and provisions of General Statutes §§ 12-217ee[1] and 12-217n,[2] which concern business tax credits for certain research and development expenses. The plaintiff, Achillion Pharmaceuticals, Inc., appealed to the Superior Court, pursuant to General Statutes § 12-237,[3] from the decision […]

Achillion Pharmaceuticals, Inc. v. Commissioner of Revenue Services, NO. CV 06 4012046S (New Britian Sup. Ct. 2008)

As a result of cross-motions for summary judgment in the above entitled case, the court issued a memorandum of decision (MOD) dated May 31, 2007, concerning the proper interpretation of General Statutes § 12-217ee (the Exchange Statute) as applied to the plaintiff’s claim for the remaining two-thirds of its 2003 rolling research and development (R&D) […]